Dipyridamole inhibits the oxidative modification of low density lipoprotein

This publication has 18 references indexed in Scilit:

• Autoantibody against oxidised LDL and progression of carotid atherosclerosis
  The Lancet, 1992
• Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis.
  BMJ, 1991
• Lipid peroxide and transition metals are required for the toxicity of oxidized low density lipoprotein to cultured endothelial cells
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
• An overview of dipyridamole
  Thrombosis Research, 1990
• Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
• The cholesterol controversy is over. Why did it take so long?
  Circulation, 1989
• Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
  Journal of Clinical Investigation, 1989
• Dipyridamole inhibits lipid peroxidation and scavenges oxygen radicals
  Lipids, 1989
• Lipid peroxides and atherosclerosis.
  BMJ, 1989
• DRUG-INDUCED INHIBITION OF PLATELET FUNCTION DELAYS PROGRESSION OF PERIPHERAL OCCLUSIVE ARTERIAL DISEASE
  The Lancet, 1985